Predictors of 30-day mortality
|
Group 1
|
95% confidence intervals
|
p value
|
---|
Age > 65 years
|
Non-survivors
|
12 (54%)
|
0.833–0.987
|
0.03*
|
Survivors
|
12 (46%)
|
Sex (males/females)
|
Non-survivors
|
19 (51%)/18(49%)
|
0.63–1.34
|
0.34
|
Survivors
|
8 (52%)/6(48%)
|
Smoking
|
Non-survivors
|
12 (60%)
|
0. 13–1.25
|
0.25
|
Survivors
|
8 (40%)
|
Mechanical ventilation
|
Non-survivors
|
8 (33%)
|
0.35–0.26
|
0.01*
|
Survivors
|
6 (22%)
|
GCS at pneumonia occurrence < 9
|
Non-survivors
|
15 (63%)
|
11.12–21.30
|
0.001*
|
Survivors
|
10 (37%)
|
Pleural effusion in CXR
|
Non-survivors
|
11 (46%)
|
0.47–1.38
|
0.99
|
Survivors
|
12 (44%)
|
Pulmonary infiltrates in CXR
|
Non-survivors
|
11 (46%)
|
0.36–1.14
|
0.224
|
Survivors
|
12 (44%)
|
PSI risk class ≥ 4
|
Non-survivors
|
15 (63%)
|
1.095–2.364
|
0.04*
|
Survivors
|
6 (22%)
|
CURB-65 scores ≥ 3
|
Non-survivors
|
18 (75%)
|
1.23–2.99
|
0.01*
|
Survivors
|
14 (52%)
|
Increased MPV/PC ratio
|
Non-survivors
|
16 (67%)
|
2.9–2.23
|
0.03*
|
Survivors
|
8 (30%)
|
- GCS Glasgow Coma Scale, NIHSS National Institutes of Health Stroke Scale, CXR chest radiograph, PSI pneumonia severity index, MPV/pc ratio mean platelet volume/platelet count ratio
- *Significant